Yang, Jin http://orcid.org/0000-0003-1002-1115
Huggins, Ashley A. http://orcid.org/0000-0001-7936-2116
Sun, Delin
Baird, C. Lexi
Haswell, Courtney C.
Frijling, Jessie L.
Olff, Miranda http://orcid.org/0000-0003-1016-9515
van Zuiden, Mirjam
Koch, Saskia B. J.
Nawijn, Laura http://orcid.org/0000-0001-7183-8933
Veltman, Dick J.
Suarez-Jimenez, Benjamin
Zhu, Xi http://orcid.org/0000-0002-9724-7231
Neria, Yuval
Hudson, Anna R. http://orcid.org/0000-0002-5752-7888
Mueller, Sven C. http://orcid.org/0000-0003-1661-3840
Baker, Justin T. http://orcid.org/0000-0002-6629-2195
Lebois, Lauren A. M. http://orcid.org/0000-0001-5816-9181
Kaufman, Milissa L.
Qi, Rongfeng http://orcid.org/0000-0002-9981-9918
Lu, Guang Ming http://orcid.org/0000-0003-4913-2314
Říha, Pavel http://orcid.org/0000-0002-1322-2038
Rektor, Ivan http://orcid.org/0000-0002-9635-7404
Dennis, Emily L. http://orcid.org/0000-0001-7112-4009
Ching, Christopher R. K.
Thomopoulos, Sophia I.
Salminen, Lauren E.
Jahanshad, Neda
Thompson, Paul M.
Stein, Dan J. http://orcid.org/0000-0001-7218-7810
Koopowitz, Sheri M.
Ipser, Jonathan C.
Seedat, Soraya
du Plessis, Stefan
van den Heuvel, Leigh L.
Wang, Li http://orcid.org/0000-0002-1459-3412
Zhu, Ye
Li, Gen
Sierk, Anika
Manthey, Antje
Walter, Henrik http://orcid.org/0000-0002-9403-6121
Daniels, Judith K.
Schmahl, Christian
Herzog, Julia I.
Liberzon, Israel http://orcid.org/0000-0002-4990-556X
King, Anthony http://orcid.org/0000-0002-0764-9625
Angstadt, Mike http://orcid.org/0000-0003-4870-7649
Davenport, Nicholas D.
Sponheim, Scott R. http://orcid.org/0000-0002-2782-0856
Disner, Seth G. http://orcid.org/0000-0003-3635-9421
Straube, Thomas
Hofmann, David
Grupe, Daniel W.
Nitschke, Jack B.
Davidson, Richard J. http://orcid.org/0000-0002-8506-4964
Larson, Christine L.
deRoon-Cassini, Terri A.
Blackford, Jennifer U. http://orcid.org/0000-0002-0261-4845
Olatunji, Bunmi O.
Gordon, Evan M. http://orcid.org/0000-0002-2276-5237
May, Geoffrey
Nelson, Steven M.
Abdallah, Chadi G. http://orcid.org/0000-0001-5783-6181
Levy, Ifat
Harpaz-Rotem, Ilan http://orcid.org/0000-0002-6066-9406
Krystal, John H. http://orcid.org/0000-0001-6952-1726
Morey, Rajendra A.
Sotiras, Aristeidis http://orcid.org/0000-0003-0795-8820
Article History
Received: 10 January 2023
Revised: 2 October 2023
Accepted: 23 October 2023
First Online: 28 November 2023
Competing interests
: LAML reports unpaid membership on the Scientific Committee for the International Society for the Study of Trauma and Dissociation (ISSTD), and spousal IP payments from Vanderbilt University for technology licensed to Acadia Pharmaceuticals unrelated to the present work. ISSTD and NIMH were not involved in the analysis or preparation of the manuscript. CRKC received partial research support from Biogen, Inc. (Boston, USA) for research unrelated to the content of this manuscript. NJ received partial research support from Biogen, Inc. (Boston, USA) for research unrelated to the content of this manuscript. PMT received partial research support from Biogen, Inc. (Boston, USA) for research unrelated to the topic of this manuscript. RJD is the founder and president of, and serves on the board of directors for, the non-profit organization Healthy Minds Innovations, Inc. CGA has served as a consultant, speaker and/or on advisory boards for Aptinyx, FSV7, Lundbeck, Psilocybin Labs, Genentech, and Janssen; served as editor of Chronic Stress for Sage Publications, Inc; and filed a patent for using mTOR inhibitors to augment the effects of antidepressants (filed on August 20, 2018). JHK is a consultant for AbbVie, Inc., Amgen, Astellas Pharma Global Development, Inc., AstraZeneca Pharmaceuticals, Biomedisyn Corporation, Bristol-Myers Squibb, Eli Lilly and Company, Euthymics Bioscience, Inc., Neurovance, Inc., FORUM Pharmaceuticals, Janssen Research & Development, Lundbeck Research USA, Novartis Pharma AG, Otsuka America Pharmaceutical, Inc., Sage Therapeutics, Inc., Sunovion Pharmaceuticals, Inc., and Takeda Industries; is on the Scientific Advisory Board for Lohocla Research Corporation, Mnemosyne Pharmaceuticals, Inc., Naurex, Inc., and Pfizer; is a stockholder in Biohaven Pharmaceuticals; holds stock options in Mnemosyne Pharmaceuticals, Inc.; holds patents for Dopamine and Noradrenergic Reuptake Inhibitors in Treatment of Schizophrenia, US Patent No. 5,447,948 (issued September 5, 1995), and Glutamate Modulating Agents in the Treatment of Mental Disorders, U.S. Patent No. 8,778,979 (issued July 15, 2014); has filed a patent for Intranasal Administration of Ketamine to Treat Depression. U.S. Application No. 14/197,767 (filed on March 5, 2014); US application or Patent Cooperation Treaty international application No. 14/306,382 (filed on June 17, 2014); and has filed a patent for using mTOR inhibitors to augment the effects of antidepressants (filed on August 20, 2018). ASotiras holds equity in TheraPanacea and has received personal compensation for serving as a grant reviewer with the BrightFocus Foundation. The remaining authors have nothing to disclose.